Kinetics of norethindrone in women; II. Single‐dose kinetics

No abstract is available for this paper.

• Publication year

  1978

• Venue

  Clinical pharmacology and therapy

• Publication date

  1978-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/cpt1978244448PMID 688734
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kinetics of norethindrone in women; I. Radioimmunoassay and concentrations during multiple dosing

  1978cited by this paper
• Investigations of pharmacokinetics of levonorgestrel to specific consideration of a possible first-pass effect in women.

  1978cited by this paper
• Bioavailability of norethindrone in human subjects

  1978cited by this paper
• First-pass effect of norethindrone in rabbits and rats.

  1978cited by this paper
• Plasma concentrations of ethynyl oestradiol and norethindrone after oral administration to women.

  1977cited by this paper
• Bioavailability of contraceptive steroids from capsules.

  1976cited by this paper
• Radioimmunoassay of norethindrone: peripheral plasma levels after oral administration to humans and rhesus monkeys.

  1974cited by this paper
• Radioimmunoassay of synthetic progestogens, norethisterone and norgestrel.

  1974cited by this paper
• The metabolic clearance rate and urinary excretion of oral contraceptive drugs. I. Norethindrone.

  1974cited by this paper
• Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

  1968cited by this paper

• The hormonal profile in women using oral contraceptives is not as stable as previously thought: a temporal analysis of serum endogenous and exogenous hormones.

  2024cites this paper
• Sorption, transport, and transformation of natural and synthetic progestins in soil-water systems.

  2020cites this paper
• Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception.

  2020cites this paper
• Formulation and characterization of norethisterone transdermal patch as an alternative route to oral administration

  2018cites this paper
• Norethindrone Acetate: Pharmacokinetics, Potency and Alternative Clinical Applications

  2017cites this paper
• Nasal Route for Delivery of Emergency Contraceptives

  2016cites this paper
• Trigger values for investigation of hormonal activity in drinking water and its sources using CALUX bioassays.

  2013cites this paper
• Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects.

  2013cites this paper
• Interindividual Variation and Drug Interactions with Hormonal Steroid Contraceptives

  2012cites this paper
• The Hormonal Profile of Norethindrone Acetate: Rationale for Add-Back Therapy With Gonadotropin-Releasing Hormone Agonists in Women With Endometriosis

  2012cites this paper
• Studies on pharmacokinetics of STS 557 in animal species and man.

  2009cites this paper
• Identification of the human cytochrome P450 enzymes involved in the in vitro biotransformation of lynestrenol and norethindrone.

  2008cites this paper
• Combined estrogen-progestogen contraceptives

  2007cites this paper
• Structure –Function Relationships, Pharmacokinetics, and Potency of Orally and Parenterally Administered Progestogens

  2007cites this paper
• Cardiovascular, anthropometric and neurocognitive features of healthy postmenopausal women: effects of hormone replacement therapy.

  2006cites this paper
• Simultaneous determination of norethindrone and ethinyl estradiol in human plasma by high performance liquid chromatography with tandem mass spectrometry--experiences on developing a highly selective method using derivatization reagent for enhancing sensitivity.

  2005cites this paper
• Tools for making correct decisions regarding hormone therapy. Part II. Organ response and clinical applications.

  2004cites this paper
• ools for making correct decisions egarding hormone therapy . Part II . rgan response and clinical applications

  2004cites this paper
• All progestins are not created equal.

  2003cites this paper
• The Effect of Food on the Bioavailability of Norethindrone and Ethinyl Estradiol from Norethindrone Acetate/Ethinyl Estradiol Tablets Intended for Continuous Hormone Replacement Therapy

  2003cites this paper
• Pharmacokinetics and Potency of Progestins used for Hormone Replacement Therapy and Contraception

  2002cites this paper
• The risk of escape ovulation under treatment with low-dose combined oral contraceptives

  2001cites this paper
• Original research article The possible role of enterohepatic cycling on bioavailability of norethisterone and gestodene in women using combined oral contraceptives

  2001cites this paper
• The possible role of enterohepatic cycling on bioavailability of norethisterone and gestodene in women using combined oral contraceptives.

  2001cites this paper
• Effect of Troglitazone on the Pharmacokinetics of an Oral Contraceptive Agent

  1999cites this paper
• A comparison of cycle control with monophasic levonorgestrel/ethinylestradiol 100 micrograms/20 micrograms versus triphasic norethindrone/ethinylestradiol 500-750-1000 micrograms/35 micrograms: a multicenter, randomized, open-label study.

  1999cites this paper
• A comparison of cycle control with monophasic levonorgestrel/ ethinylestradiol 100 μg/20 μg versus triphasic norethindrone/ ethinylestradiol 500-750-1000 μg/ 35 μg: A multicenter, randomized, open-label study

  1999cites this paper
• Oral micronized progesterone.

  1999cites this paper
• Cycle control with oral contraceptives containing 20 micrograms of ethinyl estradiol. A multicenter, randomized comparison of levonorgestrel/ethinyl estradiol (100 micrograms/20 micrograms) and norethindrone/ethinyl estradiol (1000 micrograms/20 micrograms).

  1999cites this paper
• A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 microg levonorgestrel with 20 microg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol.

  1999cites this paper
• Oral micronized progesterone

  1999cites this paper
• Predicting the oral bioavailability of 19-nortestosterone progestins in vivo from their metabolic stability in human liver microsomal preparations in vitro.

  1998cites this paper
• Bioavailability of orally administered sex steroids used in oral contraception and hormone replacement therapy.

  1996cites this paper
• Interpatient variability in bioavailability is related to the extent of absorption: Implications for bioavailability and bioequivalence studies

  1996cites this paper
• Progestin-only oral contraception: a comprehensive review.

  1994cites this paper
• Melatonin and melatonin-progestin combinations alter pituitary-ovarian function in women and can inhibit ovulation.

  1992cites this paper
• Existence of multiple peaks in plasma ethinyl estradiol and norethindrone after oral administration of a contraceptive pill.

  1992cites this paper
• Group comparison of serum ethinyl estradiol, SHBG and CBG levels in 83 women using two low-dose combination oral contraceptives for three months.

  1991cites this paper
• Effects of intranasal administration of norethisterone on folliculogenesis, cervical mucus, vaginal cytology, endometrial morphology and reproductive-endocrine profile in women.

  1991cites this paper
• The effect of tetracycline on levels of oral contraceptives.

  1991cites this paper
• Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.

  1990cites this paper
• Factors affecting the enterohepatic circulation of oral contraceptive steroids

  1990cites this paper
• Potency and pharmacokinetics of gestagens.

  1990cites this paper
• Pharmacokinetics of oestrogens and progestogens.

  1990cites this paper
• Pharmacology of contraceptive steroids: a brief review.

  1989cites this paper
• The absolute oral bioavailability of selected drugs.

  1989cites this paper
• Pharmacokinetics of norethisterone from two different combination contraceptive pills in Indian women.

  1989cites this paper
• Single dose pharmacokinetics of gestodene in women after intravenous and oral administration.

  1989cites this paper
• Triphasic Randomized Clinical Trial: comparative frequency of intermenstrual bleeding.

  1989cites this paper
• Bleeding patterns with low-dose, monophasic oral contraceptives.

  1989cites this paper
• Single dose phakmacokinetics of gestodene in women after intravenous and oral administration

  1989cites this paper
• Low-Dose Monophasic and Multiphasic Oral Contraceptives: A Review of Potency, Efficacy, and Side Effects

  1989cites this paper
• Planned Parenthood experience with triphasil.

  1987cites this paper
• Influence of aspirin on the pharmacokinetics of norethindrone.

  1987cites this paper
• Influence of aspirin on the pharma of norethindrone

  1987cites this paper
• Pharmacokinetics of norethisterone following its oral administration and by spraying it nasally or sublingually to male bonnet monkeys.

  1987cites this paper
• Comparative pharmacokinetics of levonorgestrel and ethinyloestradiol following intravenous, oral and vaginal administration.

  1987cites this paper
• [Radioimmunologic determination of the progestagen dienogest in plasma and saliva].

  1986cites this paper
• The role of pharmacokinetics in preclinical safety studies of synthetic sex steroids.

  1986cites this paper
• Pharmacokinetics of Contraceptive Steroids in Humans

  1986cites this paper
• Pharmacokinetics of oral contraceptive steroids in Egyptian women: studies with Ovral, Nordette and Norminest.

  1986cites this paper
• A non-chromatographic radioimmunoassay for 3-oxo desogestrel.

  1985cites this paper
• Norethindrone in Serum After use of an oral Contraceptive Containing Norethindrone Acetate

  1983cites this paper
• Plasma levels and pharmacokinetics of norethindrone and ethinylestradiol administered in solution and as tablets to women.

  1983cites this paper
• Interaction between phenytoin and norethisterone in the rhesus monkey.

  1983cites this paper
• Clinical Pharmacokinetics of Oral Contraceptive Steroids

  1983cites this paper
• Gastrointestinal absorption of estrone sulfate in germfree and conventional rats.

  1983cites this paper
• Atherosclerosis and Oral Contraceptive Use: Serum from Oral Contraceptive Users Stimulates Growth of Arterial Smooth Muscle Cells

  1982cites this paper
• The enzyme inducing effect of rifampicin in the rhesus monkey and its lack of interaction with oral contraceptive steroids.

  1982cites this paper
• The third S.K. & F. Prize lecture, University of London, December 1981. The clinical pharmacology of oral contraceptive steroids.

  1982cites this paper
• Pharmacokinetic and pharmacodynamic studies with vaginal devices releasing norethisterone at a constant, near zero order.

  1981cites this paper
• Farmacokinetisch belang van de serumeiwitbinding

  1981cites this paper
• Absorption of oestrone sulphate from the gastrointestinal tract of the rat.

  1981cites this paper
• Norethisterone enanthate as an injectable contraceptive in puerperal and non-puerperal women.

  1981cites this paper
• The pharmacokinetics of levonorgestrel and ethynylestradiol in women - studies with Ovran and Ovranette.

  1981cites this paper
• Terminal half-lives in plasma and bioavailability of norethisterone, levonorgestrel, cyproterone acetate and gestodene in rats, beagles and rhesus monkeys☆

  1981cites this paper
• Selective isolation procedures for GC/MS analysis of ethynyl steroids in biological material.

  1980cites this paper
• Comparative Pharmacodynamics and Pharmacokinetics of Contraceptive Steroids in Animals and Man: A Selective Review

  1980cites this paper
• Metabolism of ethynodiol diacetate in the rhesus monkey before and after administration of rifampicin.

  1980cites this paper
• Clinical pharmacology of oral contraceptive steroids: drug interactions

  1980cites this paper
• The effect of rifampicin on the pharmacokinetics of ethynylestradiol in women.

  1980cites this paper
• The pharmacokinetics of a large (3 mg) oral dose of ethynylestradiol in women.

  1980cites this paper
• PHENOBARBITONE INTERACTION WITH ORAL CONTRACEPTIVE STEROIDS IN THE RABBIT AND RAT

  1980cites this paper
• The pharmacokinetics of ethinyloestradiol in women [proceedings].

  1979cites this paper
• Terminal half-lives in plasma and bioavailability of norethisterone, levonorgestrel, cyproterone acetate and gestodene in rats, beagles and rhesus monkeys.

  1979cites this paper
• Aromatic amino acetylation in the adult and neonatal marmoset [proceedings].

  1979cites this paper
• An investigation of the pharmacokinetics of ethynylestsadiol in women using badioimmunoassay

  1979cites this paper
• The effect of rifampicin on norethisterone pharmacokinetics

  1979cites this paper
• PROCEEDINGS OF THE British Pharmacological Society 4th–6th April, 1979

  1979cites this paper
• An investigation of the pharmacokinetics of ethynylestradiol in women using radioimmunoassay.

  1979cites this paper
• Investigations of pharmacokinetics of ethinyloestradiol to specific consideration of a possible first-pass effect in women.

  1979cites this paper
• Bioavailability and pharmacokinetics of norethisterone in women after oral doses of ethynodiol diacetate.

  1979cites this paper
• Ethynylestradiol and norethindrone metabolism by everted sacs of rat ileum.

  1978cites this paper